Avanos Medical Inc.

44.63-0.3500-0.78%Vol 180.10K1Y Perf 44.07%
Apr 19th, 2021 16:00 DELAYED
BID0.0000 ASK65.00
Open44.78 Previous Close44.98
Pre-Market- After-Market-
 - -  - -%
Target Price
52.50 
Analyst Rating
Moderate Buy 2.45
Potential %
17.63 
Finscreener Ranking
★★★★+     58.86
Insiders Trans % 3/6/12 mo.
-/-/100 
Value Ranking
★★★★★     62.05
Insiders Value % 3/6/12 mo.
-/-/100 
Growth Ranking
★★★     52.39
Insiders Shares Cnt. % 3/6/12 mo.
-/-/100 
Income Ranking
 —    -
Market Cap2.14B 
Earnings Rating
Sell
Price Range Ratio 52W %
68.93 
Earnings Date
5th May 2021

Today's Price Range

44.1445.08

52W Range

24.7153.61

5 Year PE Ratio Range

-20.3060.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
0.20%
1 Month
-2.79%
3 Months
-6.71%
6 Months
18.76%
1 Year
44.07%
3 Years
-5.68%
5 Years
39.60%
10 Years
-

TickerPriceChg.Chg.%
AVNS44.63-0.3500-0.78
AAPL134.840.68000.51
GOOG2 302.404.64000.20
MSFT258.74-2.0000-0.77
XOM56.48-0.1800-0.32
WFC43.880.04000.09
JNJ162.690.45000.28
FB302.24-3.9400-1.29
GE13.460.07000.52
JPM152.65-0.6500-0.42
Financial StrengthValueIndustryS&P 500US Markets
1.70
2.80
0.16
0.20
-2.90
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
52.20
-0.30
5.70
-5.70
-6.08
RevenueValueIndustryS&P 500US Markets
534.40M
11.12
22.42
-16.54
Earnings HistoryEstimateReportedSurprise %
Q04 20200.220.2827.27
Q03 20200.140.2150.00
Q02 2020-0.080.13262.50
Q01 20200.170.16-5.88
Q04 20190.320.346.25
Q03 20190.320.30-6.25
Q02 20190.250.2812.00
Q01 20190.170.15-11.76
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.18-10.00Negative
6/2021 QR0.270.00-
12/2021 FY1.182.61Positive
12/2022 FY1.615.23Positive
Next Report Date5th May 2021
Estimated EPS Next Report0.18
Estimates Count4
EPS Growth Next 5 Years %6.30
Volume Overview
Volume180.10K
Shares Outstanding48.06M
Trades Count3.14K
Dollar Volume15.63M
Avg. Volume245.81K
Avg. Weekly Volume207.29K
Avg. Monthly Volume249.84K
Avg. Quarterly Volume248.08K

Avanos Medical Inc. (NYSE: AVNS) stock closed at 44.63 per share at the end of the most recent trading day (a -0.78% change compared to the prior day closing price) with a volume of 180.11K shares and market capitalization of 2.14B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 5380 people. Avanos Medical Inc. CEO is Joseph F. Woody.

The one-year performance of Avanos Medical Inc. stock is 44.07%, while year-to-date (YTD) performance is -2.72%. AVNS stock has a five-year performance of 39.6%. Its 52-week range is between 24.71 and 53.61, which gives AVNS stock a 52-week price range ratio of 68.93%

Avanos Medical Inc. currently has a PE ratio of -78.90, a price-to-book (PB) ratio of 1.72, a price-to-sale (PS) ratio of 4.01, a price to cashflow ratio of 155.40, a PEG ratio of 2.32, a ROA of -1.50%, a ROC of 1.56% and a ROE of -2.07%. The company’s profit margin is -6.08%, its EBITDA margin is 5.70%, and its revenue ttm is $534.40 Million , which makes it $11.12 revenue per share.

Of the last four earnings reports from Avanos Medical Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.18 for the next earnings report. Avanos Medical Inc.’s next earnings report date is 05th May 2021.

The consensus rating of Wall Street analysts for Avanos Medical Inc. is Moderate Buy (2.45), with a target price of $52.5, which is +17.63% compared to the current price. The earnings rating for Avanos Medical Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Avanos Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Avanos Medical Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 6.62, ATR14 : 1.73, CCI20 : 42.20, Chaikin Money Flow : -0.17, MACD : -0.63, Money Flow Index : 59.59, ROC : 2.03, RSI : 56.30, STOCH (14,3) : 58.10, STOCH RSI : 0.33, UO : 49.11, Williams %R : -41.90), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Avanos Medical Inc. in the last 12-months were: Gary D. Blackford (Buy at a value of $285 000)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (33.33 %)
2 (33.33 %)
2 (40.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (50.00 %)
3 (50.00 %)
2 (40.00 %)
Moderate Sell
1 (16.67 %)
1 (16.67 %)
1 (20.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.45
Moderate Buy
2.45
Moderate Buy
2.34

Avanos Medical Inc.

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.

CEO: Joseph F. Woody

Telephone: +1 844 428-2667

Address: 5405 Windward Parkway, Alpharetta 30004, GA, US

Number of employees: 5 380

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

56%44%

Bearish Bullish

68%32%

Bearish Bullish

75%25%

News

Stocktwits